| Market Cap | $28.37M-47.0% |
| Revenue (ttm) | $21.58M |
| Net Income | $1.91M |
| EPS | $0.17 |
| Shares Out | 10.87M |
| PE Ratio | 15.35 |
| Forward PE | 11.86 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 50,233 |
| Open | $2.79 |
| Previous Close | $2.84 |
| Day's Range | $2.61 - $2.85 |
| 52-Week Range | $2.61 - $6.42 |
| Beta | 1.75 |
| Analysts | Buy |
| Price Target | $6.08(+133.08%) |
| Earnings Date | Nov 5, 2026 |
About NEPH
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$NEPH stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in NEPH holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by NEPH's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
NEPH Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New NEPH patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NEPH from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from NEPH’s recent data — informational, not investment advice
What’s Behind the Score
News check: Record customer sites and double-digit growth in Q3 2026 earnings, plus analyst upgrade recommendation suggests bullish momentum despite recent weakness.
Recent Insider Activity
Insider Score Trend Over Time
-2.5 since Nov 19Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
